An ideal stroke biomarker should possess characteristics similar to cardiac troponin T (cTnT) in myocardial infarction—accurately reflecting pathophysiological changes while being detectable through rapid, efficient, and precise methods suitable for clinical use. Here, TNNT2 is linked to stroke disorder.